» Articles » PMID: 15338034

High Variability of Peptidylarginine Deiminase 4 (PADI4) in a Healthy White Population: Characterization of Six New Variants of PADI4 Exons 2-4 by a Novel Haplotype-specific Sequencing-based Approach

Overview
Specialty General Medicine
Date 2004 Sep 1
PMID 15338034
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Seven single nucleotide polymorphisms (SNPs) of the peptidylarginine deiminase 4 (PADI4) gene have recently been reported to be strongly associated with rheumatoid arthritis in Japanese individuals. These SNPs are located in or close to exons 2-4 of PADI4 and are organized in at least four different haplotypes. However, a detailed sequencing-based characterization of the PADI4 gene in other populations is still lacking. We therefore analyzed exons 2-4 of the PADI4 gene in 102 healthy white Germans individuals by DNA sequencing and characterized new variants and haplotypes by a novel haplotype-specific sequencing-based approach. The haplotypes 2/3 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*T, padi4_95*C, padi4_96*C), and haplotype 4 (padi4_89*G, padi4_90*T, padi4_92*G, padi4_94*T, padi4_104*C, padi4_95*G, padi4_96*T) conferring susceptibility to rheumatoid arthritis were detected at frequencies of 30.9% and 7.8%, respectively. In addition, three novel coding SNPs in exons 2, 3, and 4, and three SNPs in introns 2 and 3 located near the exon-intron boundaries were identified in 11 individuals (10.8%). The so-called nonsusceptibility haplotype 1 (padi4_89*A, padi4_90*C, padi4_92*C, padi4_94*C, padi4_104*C, padi4_95*G, padi4_96*T) occurred at a frequency of 58.3%. Additionally, we identified a closely related novel haplotype, haplotype 1B (2.9%), that differs from haplotype 1 only by padi4_92*G/padi4_96*C. This haplotype was not described in the Japanese population. Our results indicate that the PADI4 gene exhibits a remarkable variability and a rather complex haplotypic organization. Further studies on disease association of PADI4 should be performed by haplotype-specific sequencing-based approaches to identify the exact genotype of the PADI4 fragment of interest.

Citing Articles

PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.

Zavala-Cerna M, Gonzalez-Montoya N, Nava A, Gamez-Nava J, Moran-Moguel M, Rosales-Gomez R Clin Dev Immunol. 2014; 2013:383681.

PMID: 24454473 PMC: 3881379. DOI: 10.1155/2013/383681.


PADI2 is significantly associated with rheumatoid arthritis.

Chang X, Xia Y, Pan J, Meng Q, Zhao Y, Yan X PLoS One. 2013; 8(12):e81259.

PMID: 24339914 PMC: 3855321. DOI: 10.1371/journal.pone.0081259.


Are molecular haplotypes worth the time and expense? A cost-effective method for applying molecular haplotypes.

Levenstien M, Ott J, Gordon D PLoS Genet. 2006; 2(8):e127.

PMID: 16933998 PMC: 1550282. DOI: 10.1371/journal.pgen.0020127.


Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.

Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester G, Salama A Arthritis Res Ther. 2006; 8(2):R34.

PMID: 16469113 PMC: 1526594. DOI: 10.1186/ar1889.


Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.

Cantaert T, Coucke P, De Rycke L, Veys E, de Keyser F, Baeten D Ann Rheum Dis. 2005; 64(9):1316-20.

PMID: 15760928 PMC: 1755666. DOI: 10.1136/ard.2004.033548.


References
1.
Chavanas S, Mechin M, Takahara H, Kawada A, Nachat R, Serre G . Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6. Gene. 2004; 330:19-27. DOI: 10.1016/j.gene.2003.12.038. View

2.
Hill J, Southwood S, Sette A, Jevnikar A, Bell D, Cairns E . Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003; 171(2):538-41. DOI: 10.4049/jimmunol.171.2.538. View

3.
Nakashima K, Hagiwara T, Yamada M . Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem. 2002; 277(51):49562-8. DOI: 10.1074/jbc.M208795200. View

4.
Arita K, Hashimoto H, Shimizu T, Yamada M, Sato M . Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V. Acta Crystallogr D Biol Crystallogr. 2003; 59(Pt 12):2332-3. DOI: 10.1107/s0907444903022741. View

5.
Nielen M, van Schaardenburg D, Reesink H, van de Stadt R, van der Horst-Bruinsma I, de Koning M . Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004; 50(2):380-6. DOI: 10.1002/art.20018. View